A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

PHASE3CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

November 22, 2023

Study Completion Date

December 12, 2023

Conditions
HypoalbuminemiaHepatic Cirrhosis
Interventions
DRUG

OsrHSA

Recombinant Human Serum Albumin from Oryza Sativa

DRUG

Plasbumin®-20

Albumin (Human) 20%, USP

Trial Locations (37)

Unknown

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Youan Hospital, Capital Medical University, Beijing

Chongqing University Three Gorges Hospital, Chongqing

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou

The First Affiliated Hospital of Fujian Medical University, Fuzhou

Nanfang Hospital, Guangzhou

The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou

Huizhou Central People's Hospital, Huizhou

Affiliated Hospital of Guilin Medical University, Guilin

Liuzhou Worker's Hospital, Liuzhou

The First Affiliated Hospital of Guangxi Medical University, Nanning

Affiliated Hospital Of Zunyi Medical University, Zunyi

The Fourth Affiliated Hospital, Harbin Medical University, Harbin

Luoyang Central Hospital, Luoyang

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

The Sixth People's Hospital of Zhengzhou, Zhengzhou

Jingzhou Central Hospital, Jingzhou

TaiHe Hospital, Shiyan

The Central Hospital of Wuhan, Wuhan

Wuhan Jinyintan Hospital, Wuhan

Yichang Central People's Hospital, Yichang

Yueyang Central Hospital, Yueyang

The Third People's Hospital of Zhenjiang, Zhenjiang

First Affiliated Hospital of Gannan Medical University, Ganzhou

The First Affiliated Hospital of Nanchang University, Nanchang

Pingxiang People's Hospital, Pingxiang

Yichun People's Hospital, Yichun

Hepatobiliary Hospital Of Jilin, Changchun

The First Hospital of Jilin University, Changchun

The Sixth People's Hospital of Shenyang, Shenyang

The People's Hospital of Qinghai, Xining

Shandong Public Health Clinical Center, Jinan

West China Hospital, Sichuan University, Chengdu

The Second Affiliated Hospital of Kunming Medical University, Kunming

Ruian People's Hospital, Rui’an

The First School of Medicine, School of Information and Engineering, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

Sponsors
All Listed Sponsors
lead

Healthgen Biotechnology Corp.

INDUSTRY

NCT06355479 - A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia | Biotech Hunter | Biotech Hunter